title: Effects of the 5-HT receptor antagonists cyanopindolol, ICI 169,369, cisapride and granisetron on neuroleptic-induced catalepsy in mice.
abstract: Typical neuroleptics (e.g. haloperidol) can induce catalepsy in rodents. Selective 5-hydroxytryptamine1A (5-HT1A) receptor antagonists reduce neuroleptic-induced catalepsy (NIC), suggesting that this subtype of serotonin receptor plays a role in the modulation of nigrostriatal dopaminergic transmission. The present study was designed to evaluate the participation of other 5-HT receptor subtypes in NIC. Adult albino mice (both sexes, 26-35 g) were used. Catalepsy was induced with haloperidol (H; 1.5 mg/kg, ip) and measured at 30-min intervals by means of a bar test. Cyanopindolol (a 5-HT1B receptor antagonist), ICI 169,369 (a 5-HT1C/2 receptor antagonist) and granisetron (a 5-HT3 receptor antagonist) were used. Buspirone, a 5-HT1A partial antagonist, cisapride, a 5-HT3/5-HT4 ligand and clomipramine, a 5-HT neuronal uptake blocker, were also employed. These drugs were injected ip, 20 min before H, with each animal (9-10 per group) used only once. Cyanopindolol (0.3 mg/kg) or ICI 169,369 (5 mg/kg) did not significantly affect NIC (375 +/- 39 and 378 +/- 34 s vs 372 +/- 44 s for controls, at 2 h after H). Buspirone (1 mg/kg) reduced, while pretreatments with either granisetron (0.5 mg/kg), cisapride (5 mg/kg) or clomipramine (5 mg/kg) potentiated the cataleptic effect of H (107 +/- 19, 576 +/- 52, 815 +/- 76 and 800 +/- 97 s vs 374 +/- 40 s in the control group, at 2 h after H).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Departamento de Ciências Fisiológicas, Universidade Federal do Espírito Santo, Vitória, Brasil.
authors.forename: J G
authors.initials: JG
authors.lastname: Pires
authors.forename: A G
authors.initials: AG
authors.lastname: Ramage
authors.forename: S R
authors.initials: SR
authors.lastname: Silva
authors.forename: H A
authors.initials: HA
authors.lastname: Futuro-Neto
mesh_terms: D000818:Animals; D002065:Buspirone / Q000494:pharmacology*; D002375:Catalepsy / Q000139:chemically induced / Q000188:drug therapy*; D020117:Cisapride; D005260:Female; D017829:Granisetron / Q000494:pharmacology*; D006220:Haloperidol; D008297:Male; D051379:Mice; D010869:Pindolol / Q000031:analogs & derivatives* / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology*; D011804:Quinolines / Q000494:pharmacology*; D012702:Serotonin Antagonists; D013997:Time Factors
chemical_list: D002065:Buspirone; D020117:Cisapride; D017829:Granisetron; D006220:Haloperidol; D010869:Pindolol; D010880:Piperidines; D011804:Quinolines; D012702:Serotonin Antagonists; C047975:cyanopindolol; C054363:2-((2-(dimethylamino)ethyl)thio)-3-phenylquinoline